| Literature DB >> 23406204 |
Suxin Gui1, Xuezi Sang, Lei Zheng, Yuguan Ze, Xiaoyang Zhao, Lei Sheng, Qingqing Sun, Zhe Cheng, Jie Cheng, Renping Hu, Ling Wang, Fashui Hong, Meng Tang.
Abstract
BACKGROUND: Numerous studies have demonstrated that titanium dioxide nanoparticles (TiO2 NPs) induced nephrotoxicity in animals. However, the nephrotoxic multiple molecular mechanisms are not clearly understood.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23406204 PMCID: PMC3605279 DOI: 10.1186/1743-8977-10-4
Source DB: PubMed Journal: Part Fibre Toxicol ISSN: 1743-8977 Impact factor: 9.400
Figure 1The (101) X-ray diffraction peak of anatase TiONPs. The average grain size was about 5 nm by calculation of Scherrer’s equation.
Figure 2Transmission electron microscope image of anatase TiONPs particles. (a) TiO2 NPs powder; (b) TiO2 NPs suspended in HPMC solvent after incubation for 12 h; (c) TiO2 NPs suspended in HPMC solvent after incubation for 24 h. TEM images showed that the sizes of the TiO2 NPs powder or suspended in HPMC solvent for 12 h, 24 h were distributed from 5 to 6 nm, respectively.
Characteristics of TiONPs
| TiO2 NPs | 5.5 | Anatase | 174.8 | Ti, O | 7.57(a), 9.28(b) |
(a) Zeta potential after the 12 h incubation in 0.05% w/v HPMC solvent; (b) Zeta potential after the 24 h incubation in 0.05% w/v HPMC solvent.
Figure 3Hydrodynamic diameter distribution of TiONPs in HPMC solvent using DLS characterization. (a) Incubation for 12 h; (b) Incubation for 24 h.
Body weight, coefficient of kidney and titanium accumulation in mice kidney by intragastric administration of TiONPs for 90 consecutive days
| Net increase of body weight (g) | 22.55 ± 1.13a | 17.59 ± 0.88b | 14.22 ± 0.71c | 12.05 ± 0.61d |
| Relative weight of kidney (mg/g) | 10.07 ± 0.50a | 11.58 ± 0.58b | 13.31 ± 0.67c | 15.69 ± 0.78d |
| Ti content (ng/g tissue) | Not detected | 105 ± 5a | 193 ± 10b | 366 ± 18bc |
Different letters indicate significant differences between groups (p < 0.05). Values represent means ± SEM(N = 10).
Accumulation of metal elements in mouse kidney by intragastric administration of TiONPs for 90 consecutive days
| 0 | 1054 ± 53a | 3540 ± 177a | 2383 ± 119a | 138 ± 7a | 9.88 ± 0.49a | 1.986 ± 0.10a | 33.26 ± 1.66a |
| 2.5 | 1259 ± 63b | 3083 ± 154b | 3039 ± 152b | 159 ± 8b | 18.72 ± 0.94b | 5.69 ± 0.28b | 17.16 ± 0.86b |
| 5 | 1486 ± 74c | 2772 ± 139c | 3866 ± 193c | 215 ± 11c | 31.89 ± 1.59c | 10.27 ± 0.51c | 9.81 ± 0.49c |
| 10 | 1823 ± 91cd | 2511 ± 125d | 4839 ± 242d | 300 ± 15d | 47.88 ± 2.39d | 18.48 ± 0.92d | 2.326 ± 0.12d |
Different letters indicate significant differences between groups (p < 0.05). Values represent means ± SEM(N = 5).
Figure 4Histopathological observation of kidney caused by intragastric administration of TiONPs for 90 consecutive days. (a) Control, (b) 2.5 mg/kg TiO2 NPs, (c) 5 mg/kg TiO2 NPs, (d) 10 mg/kg TiO2 NPs. Yellow arrows indicate apoptosis or vacuolization, green arrows indicate cell abscission, fatty degeneration or cell necrosis, green virtual circle indicates infiltration of inflammatory cells, blue arrows indicate tissue necrosis or disorganization of renal tubules. Yellow virtual circle indicates TiO2 NPs aggregation. Arrow A spot is a representative cell that not engulfed the TiO2 NPs, while arrow B spot denotes a representative cell that loaded with TiO2 NPs. The right panels show the corresponding Raman spectra identifying the specific peaks at about 148 cm-1.
Figure 5Ultrastructure of kidney in male mice caused by intragastric administration of TiONPs for 90 consecutive days. (a) Control, (b) 2.5 mg/kg TiO2 NPs, (c) 5 mg/kg TiO2 NPs, (d) 10 mg/kg TiO2 NPs. Yellow arrows indicate nucleus shrinkage, chromatin marginalization, green arrows indicate mitochondria swelling, and red arrows show presence of TiO2 NPs. Arrow A spot is a representative cell that not engulfed the TiO2 NPs, while arrow B spot denotes a representative cell that loaded with TiO2 NPs. The right panels show the corresponding Raman spectra identifying the specific peaks at about 148 cm-1.
Oxidative stress in mouse kidney after intragastric administration of TiONPs for 90 consecutive days
| O2 | 18 ± 0.9a | 25 ± 1.23b | 38 ± 1.91c | 43 ± 2.15d |
| H2O2 (nmol/mg prot. min) | 31 ± 1.55a | 46 ± 2.28b | 77 ± 3.845c | 92 ± 4.6d |
| MDA (μmol/ mg prot) | 1.02 ± 0.05a | 1.97 ± 0.10b | 3.05 ± 0.15c | 4.88 ± 0.24d |
| Carbonyl (μmol/mg prot) | 0.51 ± 0.03a | 1.13 ± 0.06b | 1.89 ± 0.09c | 2.79 ± 0.14d |
| 8-OHdG (mg/g tissue) | 0.48 ± 0.02a | 2.16 ± 0.11b | 3.58 ± 0.18c | 5.87 ± 0.29d |
Different letters indicate significant differences between groups (p < 0.05). Values represent means ± SEM (N = 5).
Figure 6Functional categorization of 1246 genes. Genes were functionally classified based on the ontology-driven clustering approach of PANTHER.
RT-PCR validation of selected genes from microarray data
| Apoptosis | Apaf1 | 0.516327 | 0.699149555 | 0.5535156 |
| | Ngfrap1 | 0.15624 | 0.897360758 | 0.6713378 |
| | Cycs | 0.34444 | 0.787613639 | 0.7045653 |
| | Tnfrsf12a | 0.04954 | 0.966244365 | 0.655954 |
| | Bcl2l1 | -1.131909 | 2.191485298 | 1.663064 |
| | Birc5 | 3.213009 | 0.107841995 | 0.10103 |
| | Fn1 | 0.470814 | 0.721557364 | 0.4940369 |
| | Ccl19 | -2.490308 | 5.618978967 | 4.313047 |
| | Ccl21a | -1.826821 | 3.547545038 | 2.850085 |
| Immune/Inflammatory response | Bmp6 | -1.291201 | 2.447317025 | 40.56928 |
| | Cd55 | 0.54583 | 0.684997202 | 0.3824578 |
| | Cd74 | -1.327117 | 2.509007877 | 1.832029 |
| | Cfd | -1.861094 | 3.632830363 | 2.601335 |
| | Cfi | 1.259912 | 0.417569429 | 0.3720603 |
| | Cxcl12 | -1.913449 | 3.76708608 | 2.043431 |
| | C3 | -1.580409 | 2.990546189 | 1.886813 |
| | Cd34 | 0.282201 | 0.822335491 | 0.4588617 |
| | Bcl6 | -2.069258 | 4.196707749 | 3.073497 |
| Oxidative stress | Cygb | -1.439087 | 2.711492162 | 1.646112 |
| | Gpx7 | 0.585512 | 0.666412792 | 0.3389097 |
| | Psmb5 | 0.057543 | 0.960899198 | 0.6914788 |
| Cell cycle | Klf1 | -1.646997 | 3.131810673 | 2.100916 |
| | Bub1b | 3.216187 | 0.1076047 | 0.2573011 |
| | Txnip | -1.615053 | 3.063228525 | 1.648611 |
| Signal transduction | Egr1 | 0.348792 | 0.785241322 | 0.5866718 |
| | Nid1 | 0.918823 | 0.528940372 | 0.3838886 |
| Biological process | Odc1 | 1.576015 | 0.335407069 | 0.3957967 |
| Serpinalb | -2.035634 | 4.100028676 | 3.299695 |
Real time PCR primer pairs
| Refer-actin | Mactin-F | 5′-GAGACCTTCAACACCCCAGC-3′ | |
| | Mactin-R | 5′-ATGTCACGCACGATTTCCC-3′ | 263 |
| mApaf1-F | 5'-TAGCGGCTCATCTGTTCTGTAG-3' | | |
| | mApaf1-R | 5'-CCACTTGAAGACAAAAGACCAA-3' | 87 |
| mBcl2l1-F | 5'- ATTTCCCATCCCGCTGTG-3' | | |
| | mBcl2l1-R | 5'-GGCTAAAAGCACCTCACTCAAT-3' | 82 |
| mBcl6-F | 5'- TTTCAATGATGGACGGGTGT-3' | | |
| | mBcl6-R | 5'- ACGCAGAATGTGGGAGGAGT-3' | 118 |
| mBirc5-F | 5'-TCTAAGCCACGCATCCCA-3' | | |
| | mBirc5-R | 5'-CAATAGAGCAAAGCCACAAAAC-3' | 150 |
| mBmp6-F | 5'-ATTAAATATCCCTGGGTTGAAAGAC-3' | | |
| | mBmp6-R | 5'-CTGGGAATGGAACCTGAAAGAG-3' | 117 |
| mBub1b-F | 5'-AATGGGTGGGGCTTTTGA-3' | | |
| | mBub1b-R | 5'-CCTGGCTGCTTGTCTTGC-3' | 117 |
| mC3-F | 5'-GGAGAAAAGCCCAACACCAG-3' | | |
| | mC3-R | 5'-GACAACCATAAACCACCATAGATTC-3' | 148 |
| mCcl19-F | 5'-CCTCCTGATGCTCTGTCCCA-3' | | |
| | mCcl19-R | 5'-CGGTACCAAGCGGCTTTATT-3' | 145 |
| mCcl21a-F | 5'-CACGGTCCAACTCACAGGC-3' | | |
| | mCcl21a-R | 5'-TTGAAGCAGGGCAAGGGT-3' | 102 |
| mCd34-F | 5'-CTCAGTCCCCTGGCAGATTC-3' | | |
| | mCd34-R | 5'-GGACCCCTGTTCTCCCCTTA-3' | 147 |
| mCd55-F | 5'-AAATCCAGGAGACCAACCAAC-3' | | |
| | mCd55-R | 5'-CTGTAGATGTTCTTATTGGATGACG-3' | 113 |
| Cd74 | Cd74-F | 5'-ACGGCAAATGAAGTCAGAACA-3' | |
| | Cd74-R | 5'-AAGACTACTAATGGGTCAGAAATGG-3' | 97 |
| mCfd-F | 5'-AGCAACCGCAGGGACACTT-3' | | |
| | mCfd-R | 5'-TTTGCCATTGCCACAGACG-3' | 108 |
| Cfi-F | 5'-CCCGAGTTCCCAGGTGTTTA-3' | | |
| | Cfi-R | 5'-GAAGGAGGTCATAGCTTCAGACA-3' | 112 |
| mCxcl12-F | 5'-CCAGTCAGCCTGAGCTACCG-3' | | |
| | mCxcl12-R | 5'-TTCTTCAGCCGTGCAACAA-3' | 128 |
| Cycs | mCycs-F | 5'-CAACTCCGACTACAGCCACG-3' | |
| | mCycs-R | 5'-GACACCACTATCACTCATTTCCCT-3' | 134 |
| mCygb-F | 5'-GCTCAGTGCCCTGCATTCC-3' | | |
| | mCygb-R | 5'-CCGTGGAGACCAGGTAGATGAC-3' | 120 |
| mEgr1-F | 5'-TTACCTACTGAGTAGGCTGCAGTT-3' | | |
| | mEgr1-R | 5'-GCAATAGAGCGCATTCAATGT-3' | 141 |
| mFn1-F | 5'-TGAAGCAACGTGCTATGACGA-3' | | |
| | mFn1-R | 5'-GTTCAGCAGCCCCAGGTCTAC-3' | 149 |
| mKlf1-F | 5'-ACCACCAGATAAATCAACTCAAATG-3' | | |
| | mKlf1-R | 5'-ATAGTAACGACAACAATCCTAGCAGA-3' | 146 |
| mNgfrap1-F | 5'-GCCTTTAATGACCCGTTTGTG-3' | | |
| | mNgfrap1-R | 5'-TCCATGCTAATGGGCAACACT-3' | 147 |
| mNid1-F | 5'-ACCTCCTTTTCTTCTACTTTCACTG-3' | | |
| | mNid1-R | 5'-TCCAATTATTTAAGTAAAGACTCCCT-3' | 122 |
| mOdc1-F | 5'-TGCTGAGCAAGCGTTTGTAG-3' | | |
| | mOdc1-R | 5'-ATTCCCTGATGCCCAGTTATT-3' | 107 |
| mPsmb5-F | 5'-GCTTCTGGGAGCGGTTGTT-3' | | |
| | mPsmb5-R | 5'-CATGTTAGCGAGCAGTTTGGA-3' | 101 |
| mSerpina1b-F | 5'-TGAGTCCACTGGGCATCAC-3' | | |
| | mSerpina1b-R | 5'-GCTTCTGTTCCTGTCTCATCG-3' | 136 |
| mTnfrsf12a-F | 5'-CCAAGGACTGGGCTTAGAGTT-3' | | |
| | mTnfrsf12a-R | 5'-CCTTAGTATGGGTCGCTTTGTG-3' | 114 |
| mTxnip-F | 5'-CCTGGGTGACATTCTACATTGA-3' | | |
| mTxnip-R | 5'-TAAGGCTTAGTGAGCTTCCGAG-3' | 141 |
PCR primers used in the gene expression analysis.